Loading clinical trials...
Loading clinical trials...
Study 07-PIR-02 is a Phase 2 study designed to evaluate the safety and efficacy of NKTR-102 (PEG-irinotecan) for the treatment of patients with colorectal cancer (CRC). The study is comprised of two s...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Nektar Therapeutics
NCT07539441 · Central Nervous System Tumors, Glioma
NCT06144671 · Solid Tumor, Adult
NCT06132828 · Solid Tumor
NCT04570423 · Solid Tumors, Lymphoma
NCT07177937 · Small Cell Lung Cancer, Melanoma, and more
Investigator Site - Scottsdale
Scottsdale, Arizona
Investigator Site - Louisville
Louisville, Kentucky
Investigator Site - Dallas
Dallas, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions